Opportunity Information: Apply for RFA AT 14 005
Apply for RFA AT 14 005
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Health Services and Observational Studies of Non Pharmacological Approaches to Managing Pain and Co Morbid Conditions in U.S. Military Personnel, Veterans, and their Families (R01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.213 Research and Training in Complementary and Integrative Health 93.279 Drug Abuse and Addiction Research Programs.
- This funding opportunity was created on Oct 18, 2013 and posted on Jul 1, 2013.
- Applicants must submit their applications by Nov 1, 2013. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: For profit organizations other than small businesses State governments City or township governments Small businesses Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education County governments Special district governments Independent school districts Public and State controlled institutions of higher education Public housing authorities/Indian housing authorities Others (see text field entitled Additional Information on Eligibility for clarification) Native American tribal governments (Federally recognized) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are not eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The NIH grant opportunity RFA-AT-14-005, titled "Health Services and Observational Studies of Non Pharmacological Approaches to Managing Pain and Co Morbid Conditions in U.S. Military Personnel, Veterans, and their Families (R01)," was a discretionary research grant announcement intended to support studies that examine real-world, non-drug approaches for managing pain and closely related health problems in U.S. service members, Veterans, and, where relevant, their families. The emphasis is on health services research and observational research rather than early-stage lab work or narrowly controlled efficacy trials. In practice, that means the FOA was looking for projects that can describe, compare, or evaluate how non pharmacological interventions are actually being used in clinical or community settings, what outcomes they are associated with, and what barriers or facilitators affect access, quality, adherence, and implementation.
A central goal of the FOA is to address pain in the context in which it commonly appears for military populations: alongside other significant and often overlapping conditions such as post traumatic stress disorder (PTSD), traumatic brain injury (TBI), substance use disorder (SUD), depression, anxiety, and sleep disturbances. The announcement highlights symptom management for pain and these co-morbid issues, reflecting the reality that pain is frequently intertwined with behavioral health, neurologic injury, and sleep problems in returning and former service members. The FOA also signals strong public health motivation, specifically calling out the need to respond to challenges faced by troops returning from recent conflicts.
In terms of the populations of interest, the opportunity is broadly inclusive of all branches and components of the U.S. military. That includes the Army, Navy, Marines, Air Force, and Coast Guard, as well as the U.S. Military Reserves and National Guard. While studies involving any military or Veteran population were relevant, the FOA states that individuals who are serving or who have served in Operation Enduring Freedom (Afghanistan), Operation Iraqi Freedom (Iraq), and Operation New Dawn are of special interest. This focus reflects the heightened urgency around the health consequences seen in OEF/OIF/OND cohorts, including complex pain presentations and mental health co-morbidities, and the practical need for scalable, non-drug strategies within military and Veteran health systems.
The scientific scope centers on non pharmacological approaches to symptom management. While the announcement does not list specific modalities in the excerpt provided, the framing and the associated NIH program context point toward complementary, integrative, behavioral, and rehabilitative strategies that do not rely on medications. The intent is to generate evidence that is useful for decision-making in real health care environments: what types of non pharmacological care are being used, for whom, under what circumstances, and with what outcomes and resource implications. Because the FOA is explicitly limited to health services and observational studies, strong applications would typically be expected to use designs suited to real-world care delivery questions, such as cohort studies, registry analyses, analyses of administrative or electronic health record data, pragmatic observational comparisons, implementation-focused evaluations, and studies that assess utilization patterns, patient-reported outcomes, quality of care, and system-level factors.
Administratively, the opportunity used the NIH R01 mechanism, meaning it supported investigator-initiated, multi-year research projects of the size and rigor typical for an R01. It was posted July 1, 2013, with an original closing date of October 11, 2013, later updated to November 1, 2013, and it was archived December 1, 2013. No cost sharing or matching was required, which is consistent with many NIH research grant opportunities.
Eligibility was broad and included many kinds of U.S.-based organizations: for-profit organizations (including small businesses), nonprofit organizations (including 501(c)(3) and non-501(c)(3) entities), public and private institutions of higher education, and multiple levels of government such as state, county, city or township, special district governments, independent school districts, and public housing authorities/Indian housing authorities. The FOA also explicitly includes a range of mission- and community-focused institutions and groups, such as Historically Black Colleges and Universities (HBCUs), Hispanic-Serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), as well as faith-based or community-based organizations, eligible federal agencies, regional organizations, U.S. territories or possessions, and tribal governments (including federally recognized tribes and other Indian/Native American tribal governments). At the same time, the FOA clearly restricts applications to domestic entities: non-U.S. (foreign) institutions were not eligible to apply, non-domestic components of U.S. organizations were not eligible, and foreign components as defined by NIH policy were not allowed.
From a program classification standpoint, the FOA lists CFDA numbers 93.213 (Research and Training in Complementary and Integrative Health) and 93.279 (Drug Abuse and Addiction Research Programs). That pairing reinforces the announcement's dual emphasis: building evidence on non pharmacological and integrative approaches to pain and symptom management, while also being attentive to the substance use dimension that can co-occur with chronic pain and mental health conditions in military and Veteran populations.
Finally, the sponsoring agency was the National Institutes of Health, and the official announcement and details were hosted through the NIH grants guide. For technical issues accessing the opportunity, the contact listed is the NIH Office of Extramural Research (OER) Webmaster.
FAQs: NIH RFA-AT-14-005 (R01)
What is the name and number of this NIH funding opportunity?
The opportunity is NIH RFA-AT-14-005, titled "Health Services and Observational Studies of Non Pharmacological Approaches to Managing Pain and Co Morbid Conditions in U.S. Military Personnel, Veterans, and their Families (R01)."
What is the main purpose of this FOA?
Its purpose is to support discretionary research studies that examine real-world, non-drug approaches for managing pain and closely related co-morbid conditions in U.S. military personnel, Veterans, and, where relevant, their families. The emphasis is on evidence that helps understand how these approaches are used in practice, what outcomes they are associated with, and what affects access and implementation in real settings.
What type of research does this FOA prioritize?
The FOA prioritizes health services research and observational research. It is oriented toward studies that describe, compare, or evaluate non pharmacological interventions as they are actually delivered in clinical or community environments, rather than early-stage laboratory work or narrowly controlled efficacy trials.
Does the announcement focus on medications or non-drug strategies?
It focuses on non pharmacological (non-drug) approaches to symptom management for pain and related conditions.
Which health issues are specifically highlighted alongside pain?
The FOA highlights pain in the context of co-morbid and overlapping conditions common in military populations, including post traumatic stress disorder (PTSD), traumatic brain injury (TBI), substance use disorder (SUD), depression, anxiety, and sleep disturbances.
Why does the FOA emphasize co-morbid conditions?
Because, in returning and former service members, pain frequently occurs alongside behavioral health concerns, neurologic injury, substance use issues, and sleep problems. The FOA frames symptom management as a connected set of challenges rather than pain in isolation.
Who are the populations of interest for this funding opportunity?
The FOA is broadly inclusive of U.S. military personnel and Veterans across all branches and components, and it can include families where relevant.
Which branches and components of the military are included?
The scope includes the Army, Navy, Marines, Air Force, and Coast Guard, as well as the U.S. Military Reserves and National Guard.
Are any specific deployment cohorts called out as a priority?
Yes. The FOA states that individuals who are serving or who have served in Operation Enduring Freedom (Afghanistan), Operation Iraqi Freedom (Iraq), and Operation New Dawn are of special interest.
Does this FOA include family members in the study population?
Yes, where relevant. The title and description indicate that families may be included when appropriate to the research question.
What kinds of study questions fit the FOA's "real-world" emphasis?
Examples of the types of questions aligned with the FOA include: how non pharmacological interventions are being used in clinical or community settings; what outcomes are associated with their use; and what barriers or facilitators affect access, quality, adherence, and implementation.
What kinds of data sources and study designs are implied as a good fit?
Because the FOA is limited to health services and observational studies, it points toward designs suited to care delivery questions, such as cohort studies, registry analyses, analyses of administrative or electronic health record data, pragmatic observational comparisons, implementation-focused evaluations, and studies assessing utilization patterns, patient-reported outcomes, quality of care, and system-level factors.
Does the FOA list specific non pharmacological modalities that must be studied?
Not in the information provided here. The description frames the scope broadly as non pharmacological approaches and notes the context of complementary, integrative, behavioral, and rehabilitative strategies, but it does not list specific required modalities in the excerpt.
What funding mechanism does this opportunity use?
It uses the NIH R01 mechanism, supporting investigator-initiated, multi-year research projects of the size and rigor typical for an R01.
When was this FOA posted and when did it close?
It was posted on July 1, 2013. The original closing date was October 11, 2013, and it was later updated to November 1, 2013.
Is this funding opportunity still active?
No. It was archived on December 1, 2013.
Is cost sharing or matching required?
No. The FOA states that no cost sharing or matching is required.
What types of organizations are eligible to apply?
Eligibility is broad and includes U.S.-based for-profit organizations (including small businesses), nonprofit organizations (including 501(c)(3) and non-501(c)(3) entities), public and private institutions of higher education, and multiple levels of government (state, county, city or township, special district governments, independent school districts, and public housing authorities/Indian housing authorities).
Are community-based and faith-based organizations eligible?
Yes. The FOA explicitly includes faith-based or community-based organizations as eligible applicants (as long as they meet the domestic eligibility requirements).
Are minority-serving institutions included in eligibility?
Yes. The FOA explicitly includes institutions such as Historically Black Colleges and Universities (HBCUs), Hispanic-Serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs).
Are tribal governments eligible to apply?
Yes. The FOA includes tribal governments, including federally recognized tribes and other Indian/Native American tribal governments.
Are U.S. territories or possessions eligible?
Yes. The FOA includes U.S. territories or possessions as eligible applicants.
Are foreign (non-U.S.) institutions allowed to apply?
No. The FOA restricts applications to domestic entities. Non-U.S. (foreign) institutions are not eligible to apply.
Can a U.S. organization submit an application that includes a non-domestic component?
No. The FOA states that non-domestic components of U.S. organizations are not eligible, and foreign components (as defined by NIH policy) are not allowed.
What are the CFDA numbers associated with this opportunity?
The FOA lists CFDA 93.213 (Research and Training in Complementary and Integrative Health) and 93.279 (Drug Abuse and Addiction Research Programs).
What do the CFDA numbers suggest about the program emphasis?
They reinforce a dual emphasis on generating evidence about non pharmacological and integrative approaches to pain and symptom management while remaining attentive to substance use and addiction research issues that can co-occur with pain and mental health conditions in military and Veteran populations.
Which federal agency sponsors this FOA?
The sponsoring agency is the National Institutes of Health (NIH), and the official announcement and details were hosted through the NIH grants guide.
Who is the contact for technical issues accessing the opportunity?
For technical issues accessing the opportunity, the contact listed is the NIH Office of Extramural Research (OER) Webmaster.
Browse more business programs for Military Services, Veteran Support Organizations
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Education Health
Next opportunity: San Joaquin River Restoration Program (SJRRP)
Previous opportunity: Pilot and Feasibility Studies of Non Pharmacological Approaches to Managing Pain and Co Morbid Conditions in U.S. Military Personnel, Veterans, and their Families (R34)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA AT 14 005
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA AT 14 005) also looked into and applied for these:
| Funding Opportunity |
|---|
| NIDA Program Project Grant Applications (P01) Apply for PAR 13 259 Funding Number: PAR 13 259 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Synergizing Omic and Symptom Science (R15) Apply for PA 13 265 Funding Number: PA 13 265 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
| Synergizing Omic and Symptom Science (R01) Apply for PA 13 264 Funding Number: PA 13 264 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Grand Opportunity in Medications Development for Substance Use Disorders (U01) Apply for PAR 13 270 Funding Number: PAR 13 270 Agency: National Institutes of Health Category: Education Health Funding Amount: $5,000,000 |
| Revision Applications to Promote Collaborative Research on Addiction at NIH (CRAN) Comorbidity Related Research (R01) Apply for RFA DA 14 014 Funding Number: RFA DA 14 014 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
| Administrative Supplements to Promote Collaborative Research on Addiction at NIH (CRAN) Comorbidity Related Research (Admin Supp) Apply for PA 13 275 Funding Number: PA 13 275 Agency: National Institutes of Health Category: Education Health Funding Amount: $100,000 |
| Abuse Resistant and Abuse Deterrent Formulations and Devices to Avoid the Abuse, Misuse and Diversion of Prescription Opioids by Patients (SBIR)(R43/R44) Apply for RFA DA 14 013 Funding Number: RFA DA 14 013 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R21) Apply for PAR 13 282 Funding Number: PAR 13 282 Agency: National Institutes of Health Category: Education Health Funding Amount: $175,000 |
| NLM Career Development Award in Biomedical Informatics (K01) Apply for PAR 13 284 Funding Number: PAR 13 284 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Building Evidence Effective Palliative/End of Life Care Interventions (R01) Apply for PAR 13 289 Funding Number: PAR 13 289 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| NLM Express Research Grants in Biomedical Informatics (R01) Apply for PAR 13 300 Funding Number: PAR 13 300 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| Advanced Development of Informatics Technology (U24) Apply for PAR 13 294 Funding Number: PAR 13 294 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| Revisions to P01 Awards for Research on Detection of Pathogen Induced Cancer (DPIC) (P01) Apply for PAR 13 297 Funding Number: PAR 13 297 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
| Revisions to P50 Awards for Research on Detection of Pathogen Induced Cancer (DPIC) (P50) Apply for PAR 13 298 Funding Number: PAR 13 298 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
| Revision Applications to P01 Awards for Research on Imaging and Biomarkers for Early Cancer Detection (P01) Apply for PAR 13 317 Funding Number: PAR 13 317 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
| Revision Applications to P50 Awards for Research on Imaging and Biomarkers for Early Cancer Detection (P50) Apply for PAR 13 318 Funding Number: PAR 13 318 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
| National Cancer Institute Program Project Applications (P01) Apply for PAR 13 321 Funding Number: PAR 13 321 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Increased Knowledge and Innovative Strategies to Reduce HIV IncidenceiKnow Projects (R01) Apply for PAR 13 323 Funding Number: PAR 13 323 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Innovative Molecular Analysis Technology Development for Cancer Research and Clinical Care (SBIR R43/44) Apply for PAR 13 327 Funding Number: PAR 13 327 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Revisions for Early Stage Development of Informatics Technology (P01) Apply for PAR 13 330 Funding Number: PAR 13 330 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA AT 14 005", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.